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ABSTRACT 
We have cultured myogenic cells derived from primary explants and a cell line 
(L6) in  a  lipid-depleted  medium  (LDM)  and  produced  large  alterations  of the 
fatty acyl and polar headgroup composition and of the cellular sterol levels. These 
alterations were produced by altering the composition of the  media as follows: 
removing  biotin  and  providing  exogenous  fatty  acid;  removing  choline  and 
providing exogenous ethanolamine or choline analogues; and by adding 25-OH 
cholesterol, an inhibitor of 3-hydroxy-3-methylglutarate (HMG)-CoA reductase. 
Relatively small, secondary alterations of other lipid classes accompany the large 
primary  alteration.  In  general,  they  are  not  obviously  compensatory  for  the 
primary alteration by retaining some physical property. 
We  have  explored  the  influence  of  these  lipid  alterations  on  myoblast 
proliferation  and  fusion  into  myotubes.  In  general,  considerable  variability 
appears tolerated, but there also appear to be limits. Long-term cultures grown 
in media containing a  single fatty acid do not proliferate indefinitely, and the 
fatty acid does not become the sole fatty acyl component of the phospholipids. 
This phenomenon is also observed for cultures enriched in phosphatidylethanol- 
amine (PE) or phosphatidyldimethylethanolamine (PDME). 
The influence of the lipid alterations on fusion is particularly interesting. The 
inclusion  of 25-OH  cholesterol inhibits  fusion.  Enrichment  of the  fatty  acyl 
chains with elaidate or the polar headgroups with PE also inhibits fusion, but in 
contrast to that by 25-OH cholesterol, a significant fraction of the myoblasts are 
aligned and interacting with each other. Oleate enrichment enhances the rate of 
fusion. 
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Myogenic cells derived from primary explants or 
available as continuous cell lines can be grown in 
culture  while  retaining  many of their  differen- 
tiated membrane properties. When grown under 
suitable  culture  conditions,  for  example,  they 
sort out and fuse into multinucleate myotubes, 
synthesize acetylcholine receptors, become elec- 
trically  and  chemically  excitable,  cluster  their 
receptors into  "hot spots",  and  form synapses 
with  appropriate  neurons  (17-20,  22,  25,  34, 
37, 41,43, 50, 56, 57, 59, 61). It is likely that the 
synthesis  and assembly of the relevant molecular 
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of these phenomena directly or indirectly involve 
the  membrane lipids.  One approach  to  demon- 
strate such a lipid involvement and elucidate the 
nature of its coupling to a  membrane process  is 
via  select  alterations of the  synthesis  and com- 
position  of  membrane components  (11,  26,  27, 
39, 54). 
We  reported  previously that  it  is  possible  to 
exert such control on the fatty acyl chains of 3T3 
and SV  101-3T3  cells and retain some  of their 
characteristic properties, e.g., differential agglu- 
tinability (23,  28).  Using L  cells which do  not 
require serum, Williams et al. (60) and Ferguson 
et  ai.  (16)  have  also  reported  procedures  for 
altering  the  fatty  acyl  composition.  More  re- 
cently,  Glaser  et  al.  (21)  and  Blank  et  al.  (5) 
have  demonstrated  alterations  in  the  phospho- 
lipid composition of L  cells by growing them in 
the  presence of choline analogues, and Chen et 
al. (10,  31) have reported changes in their levels 
of  sterol  induced  by  inhibitors  of  3-hydroxy-3- 
methylglutaryl  (HMG)1-CoA  reductase.  In  this 
communication, we  extend  these  methods  to  in- 
clude  myogenic  cells  derived  from  primary  ex- 
plants of chick pectoral muscle and Lr, a myogenic 
cell line, and describe procedures for altering the 
composition of their fatty acyl chains, the ratio of 
phosphatidylethanolamine (PE)  to  phosphatidyl- 
choline (PC), and the levels of cellular sterol. We 
also  show  that  large,  secondary  lipid alterations 
do  not  accompany  the  primary  alterations.  In 
addition,  we  present  our  observations  on  the 
influence of  altered  lipid  compositions on  myo- 
blast  proliferation  and  fusion  into  multinucleate 
myotubes. Preliminary accounts of this work have 
appeared  elsewhere  (26,  27,  29).  During  the 
Abbreviations used in this paper: AraC, cytosine arabi- 
noside; CMF-PBS, calcium- and magnesium-free phos- 
phate-buffered  saline;  DME,  dimethylethanolamine; 
DMEM,  Dulbecco's  modified  Eagle's  medium; 
EGTA,  ethylene  glycol-bis(/i-aminoethyl  ether)- 
N,N,N',N'-tetraacetate;  HMG,  3-hydroxy-3-methyl- 
glutarate; LDM, lipid-depleted medium (comprised of 
DMEM  and  13%  lipid-extracted  fetal  calf  serum); 
LDMA,  lipid-depleted  medium  containing 2  /zg/ml 
avidin; LDMB, lipid-depleted medium containing bio- 
tin-1.25 /zg/ml  (primaries)or 1.5  /zg/ml  (Lr); PBS, 
phosphate-buffered saline (35, 42); PC, phosphatidyl- 
choline;  PDME,  phosphatidyldimethylethanolamine; 
PE, phosphatidylethanolamine; PI, phosphatidylinosi- 
tol; PPLO, pleuropneumonialike organisms; PS, phos- 
phatidylserine; Sph, sphingomyelin. 
course  of  these  studies,  Schroeder  et  al.  (49) 
reported  an analogous procedure for altering the 
ratio of PE to PC in LM cells. 
MATERIALS  AND  METHODS 
Preparation of Lipid-Depleted 
Fetal Calf Serum 
Lipid-depleted  fetal  calf  serum  was  prepared  as 
described previously for calf serum except that 100 ml 
of serum  was  used  instead of 55  ml,  and the  dried 
residue  (~4.8  g)  was  resuspended  into  100  mi  of 
distilled water  (28).  Both  fetal  calf  serum  and  the 
extracted  and  reconstituted fetal  calf  serum  contain 
18 mg/ml protein (40). The extracted serum contains 
<0.5%  (0.18  nmol/ml) of the  original phospholipid 
which consists of lecithin (57.4%), sphingomyelin (Sph) 
(24.3%) and lysolecithin  (18.2%); 0.06% (1.3 /zg/ml) 
of the original sterol which is almost exclusively choles- 
terol; and 2.5% (5.0/zg/ml) of the original fatty acids 
and  esters  which  are  primarily  16:0  (24.3%),  16:1 
(4.0%),  18:0 (16.2%),  18:1  (25.7%),  18:2  (4.0%), 
and 20:4 (24.3 %). The relative amounts of the residual 
fatty acids and esters present in the extracted serum 
are  16:0  (41.7%),  16:1  (4.2%),  18:0  (37.5%),  and 
18:1 (12.5%). 
Cell Growth 
Primary  myogenic cultures  were  prepared  by  the 
method of Bischoff and Holtzer (4) with several minor 
modifications. Pectoral muscle was dissected from 11- 
day chick embryos, placed into calcium- and magnesium- 
free  phosphate-buffered  saline  (CMF-PBS),  and  the 
connective tissue  was  removed. The  muscle  was  then 
teased  into small pieces  and placed  into a  sterile  tube 
containing 0.25% trypsin  in CMF-PBS for 30-45 rain. 
When the tissue  appeared dissociated,  the growth me- 
dium (with serum) was added. The cell suspension was 
pipetted several times to disperse the cells and then spun 
at 900-1000 rpm for 2-3 min in a desk  top centrifuge 
(HN-S, 1EC Corp., Austin, Tex.). The supernatant was 
removed and 10 ml of growth medium (with serum) was 
added.  The  pellet was  then  resuspended and filtered 
through  a  Swinney filter apparatus  (Millipore  Corp., 
Bedford,  Mass.)  containing a  double thickness of un- 
coated lens paper (Arthur H. Thomas Co,, Philadelphia, 
Pa., no. 6325). An aliquot of the cell suspension  was 
diluted ten-fold and counted. The cells were then diluted 
to 0.25-0.5  x  106 cells/ml  (depending on the experi- 
ment)  and  plated  into  collagen-coated  plastic  tissue 
culture dishes (35 mm, 2 ml; 100 mm, 16 ml). 
All manipulations were performed under sterile con- 
ditions,  and  CMF-PBS  as  well  as  the  final growth 
medium  contained  1%  penicillin-streptomycin-fungi- 
zone (antibiotic-antimycotic  mixture, Grand Island Bi- 
ological  Co. (GIBCO), Grand Island, N,Y.  [100  ￿ 
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of myogenic cells was usually between 60 and 90%. 
Primary  myoblasts were  prepared  by  growing  the 
explanted myogenic cells  in  regular medium (or lipid- 
depleted  medium  [LDM])  made  without  exogenous 
calcium and containing 200-300 p,M ethylene glycol-bis 
(fl-aminoethyl  ether)N,N,N',N'-tetraacetate  (EGTA) 
(62). The EGTA was added 3 h after plating. Cytosine 
arabinoside (AraC, 1 p,g/ml) was added on the 2nd day 
after  plating  (18),  and  the  cells  were  harvested  for 
analysis on day 3. 
Myotubes were obtained from myogenic cells grown 
in  regular  medium or LDM  containing the indicated 
supplements.  AraC  (1  /zg/ml)  was  added  on  day  2, 
and the cells were harvested for analysis or scored for 
fusion on  day  3,  unless otherwise indicated. Control 
cultures contained ~70%  of the nuclei in myotubes, 
and  in  the  lipid-altered  cells  the  extent  of  fusion 
depended on the nature of the supplement. 
Preformed myotubes were obtained by growing my- 
ogenic cells in LDM containing 2 p,g/ml avidin (LDMA) 
(for fatty acyl alterations) or LDM containing 1.25  p.g/ 
ml  biotin  (LDMB)  (for  sterol  and  polar  headgroups 
alterations)  for  3  days.  At  this  time,  the  designated 
supplements were added and the cells were harvested for 
analysis after two additional days of growth (day  5) for 
fatty  acid  and  polar  headgroup  alterations,  or  three 
additional days growth (day 6) for sterol alterations. 
Primary myogenic cells with altered fatty acyl com- 
positions were prepared by terminating the trypsin dis- 
sociation of the primary explant with LDMA. The ceils 
were then centrifuged and resuspended into LDMA at a 
concentration of 0.25  ￿  l0  s ceUs/ml and pipetted into 
tissue  culture  plates as described above. Fatty acid  or 
biotin was added at the indicated concentration (5-50 
txg/ml or  1.25  txg/ml, respectively) within  3-4  h  after 
plating  or on day  3  (for alterations of preformed my- 
otubes). For polar headgroup alterations, the primary 
myogenic cells were plated in LDMB at a concentration 
of 0.25  ￿  l0  s cells/ml.  Ethanolamine or dimethylethan- 
olamine (DME) was added at the indicated concentra- 
tion  (2.8-100  /xg/ml or  4  /zg/rnl,  respectively) 2-4  h 
after  plating.  For  sterol  alterations,  the  primary  my- 
ogenic ceils were plated at a concentration of 0.5  ￿  l0  s 
cells/ml in LDMB, and after 3-4 h, 0.63  /zg/ml 25-OH 
cholesterol was added. When cholesterol was also pres- 
ent, it  was added at  a  final  concentration of 5  p,g/ml 
either simultaneously  with the 25-OH cholesterol or at 
the  stated  time.  For  sterol  alterations  of  preformed 
myotubes, the 25-OH cholesterol was added on day 3 at 
a concentration of 1.2/.~/ml. 
Ls 
Stock cultures of I_~  (61),  a  rat  myogenic cell  line 
obtained  from  D.  Schubert  (Salk  Institute, La  JoUa, 
Calif.), or a clone derived from it were grown in tissue 
culture  flasks  containing Dulbecco's Modified Eagle's 
medium  (DMEM)  and  10%  fetal calf serum  (termed 
regular  medium).  The  stocks  were  subcultured  with 
trypsin  and  EDTA  well  before confluence every  3rd 
day. The cells were free of pleuropneumonialike orga- 
nisms  (PPLO) as assayed  by  a  fluorescence technique 
and  by  incorporation  of  [aH]thymidine  followed  by 
autoradiography (38, 47). 
For growth curves and compositional analyses, cells 
were plated into tissue culture dishes containing 2  ml 
(35  mm), 5 ml (60 ram), or 15  ml (100 ram), respec- 
tively, of regular medium or DMEM and  13%  lipid- 
depleted fetal calf serum (termed LDM). For experi- 
ments involving fatty acyl  synthesis and composition, 
avidin was present in LDM at a concentration of 2 ~,g/ 
ml (LDMA). Additional supplements were added 2-4 
h  after plating. The  ceils  were  grown at  37~  in  an 
atmosphere containing  10%  CO2  and  counted  in  a 
hemacytometer after removal from the substratum with 
trypsin and EDTA. A factor of 28.3 cmZ/60-mm plate 
was used to calculate the cell density. The cell density 
is expressed as the mean with standard deviation of the 
number  of  determinations shown  by  the  integer  in 
parentheses. 
Long- Term Growth 
L6 was plated at a  density of 6  ￿  104 cetls/60-mm 
plate or at  1.8  ￿  105  cells/75cm  2 flask (oleate), and 
additions were made as described above. On day 4-5, 
the  cells  were  removed  from  the  substratum  with 
trypsin-EDTA, and LDMB (LDM +  1.50  p,g/ml bio- 
tin) (for sterol and polar headgroup modifications) or 
LDMA (LDM +  2 p,g/ml avidin) (for fatty acyl altera- 
tions), was added. The cells were counted and replated 
at 6 ￿  104 or 1 x  105 ceUs/60-mm plate or at 1.8  x  105 
cells/75  cm2-flask,  and  additions were  made  as  de- 
scribed above. This process was repeated through the 
indicated number of passages. 
Lipid Analyses 
Cultured plates washed once with versine and  har- 
vested  with  EDTA  and  trypsin  were  washed  2￿  in 
phosphate-buffered saline  (PBS) or versine by centrifu- 
gation and extracted by the method of Bligh and Dyer 
(6). The chloroform was evaporated under a stream of 
argon, and the residue was resuspended into ~20 ~1 of 
chloroform and applied to Absorbsil 5 prekotes (Applied 
Science Laboratories, State College, Pa.). The thin-layer 
plate  was  developed  with  a  solvent  of  chloroform: 
methanol:acetic acid:water  (75:45:8:2)  (55),  and  the 
two-dimensional system of Glaser et al.  (21)  was used 
to  resolve  phospholipids  derived  from  monomethyl- 
ethanolamine and dimethylethanolarnine. 
For phospholipid analyses, the chromatograms were 
visualized  by exposure to iodine vapors, and the spots 
were identified by comparison to a set of standards and 
to  published R~  values.  The  regions of the  silica  gel 
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ml  of  10  N  H~SO4 was added,  and  the  mixture  was 
heated to 160~  for 3 h. After cooling, 0.5 ml of HzO2 
(30%)  was  added,  and  the  samples  were  heated  at 
160~  for 2 h. After cooling again, 0.2 ml of ammonium 
molybdate  (5%  in  H20),  0.2  ml  of  Fiske-Subbarow 
reagent, and 4.4 ml water were added; the tubes were 
covered with aluminum foil, and the mixture was heated 
for 7 min at 100~  The OD was read at 802 tit against 
appropriate blanks and compared to standards carried 
out through the same procedure (1; G. Khuller and H. 
Goldfine, personal communication). 
For fatty  acyl  analyses, the  lipids were chromato- 
graphed  as  described  above,  visualized  by  a  water 
spray,  and  the  regions  of  the  silica  gel  containing 
phospholipid were  collected and  eluted  with  chloro- 
form:methanol (1 : t ) followed by chloroform:methanol 
(2:1). The extract was dried under a  stream of argon 
and transesterified by resuspension into BFz-methanol 
reagent (Applied Science Laboratories) followed by an 
incubation for  10  min in boiling water. After cooling 
on ice,  1 ml each of pentane and water were added, 
the mixture was vortexed, and  the  upper phase was 
removed. The extraction was repeated twice, and the 
upper  (pentane)  phases  were  collected  and  concen- 
trated. The methyl esters were analyzed by gas chro- 
matography on a 6-foot column of EGSS-x or a 20-foot 
column of Silar  10c  on  100/120  mesh Gas Chrom Q 
(Applied  Science  Laboratories)  using  nitrogen  as  the 
carrier gas. In some experiments, the former column was 
temperature-programmed between 180 ~ and 205~  and 
the latter run at 220~  The Silar 10c column was used 
to separate cis and trans isomers. The fatty acid  peaks 
were identified by  comparing their retention times to 
those of standards. Peaks corresponding to unusual fatty 
acids, those that varied from determination to determi- 
nation, and those with retention times longer than that 
of 20:4 were not determined. The relative areas under 
the  peaks  were  estimated  using  the  peak  height  by 
retention time method along with triangulation. 
The ratio of 16/18 carbon fatty acids was determined 
by dividing the fraction of 16-carbon fatty acids by the 
fraction  of  18-carbon  fatty  acid.  The  percentage of 
unsaturated fatty acids is defined as the fraction of fatty 
acids possessing one or more double bonds multiplied 
by 100. The number of double bonds is determined by 
adding together the percent of each type of unsaturated 
fatty acid multiplied by its number of double bonds. 
The  levels  of  cellular  sterol  were  determined  as 
follows (2):  Pellets of harvested cells were sonicated 
for 20  s on  ice,  an  aliquot was removed for protein 
determination (40), and coprostanol was added as an 
internal standard. The  sonicate was extracted by the 
method  of  Bligh  and  Dyer  (6),  and  the  chloroform 
phase  was  evaporated under  a  stream  of nitrogen or 
argon. The residue was taken up into CSz and analyzed 
by  gas  chromatography using a  6-foot glass  column 
containing OV-17  on  100/120  mesh  Gas  Chrom  Q. 
The column was run at 250~  using Nz as the carrier 
gas.  The  sterols were  identified by  comparing their 
retention times to those of standards. In some cases, 3/,, 
of the chloroform phase was removed for determination 
of total phospholipid, leaving  the remainder for sterol 
analysis. 
All analyses are presented as the mean with standard 
deviation of the number of determinations shown by 
the integer in parentheses. 
Fusion 
3-day-old cultures were generally fixed and stained 
to facilitate scoring fusion. Two methods were used. In 
the initial  experiments, the culture plates were washed 
2x with PBS, aspirated well, and 100% methanol was 
added for  15  rain.  The  methanol was aspirated  and 
replaced  in  5-rain  intervals  by  30,  70,  and  100% 
ethanol.  After  the  last  ethanol  treatment,  10% 
aqueous  Giemsa's (obtained as  a  concentrated stock 
from Harleco [Gibbstown, N. J.], diluted to  10%  and 
filtered through Whatman no. 2 filter paper) was added 
for 30 min. The plate was rinsed in deionized water and 
covered with glycerol.  In later experiments, a different 
procedure was used,  The  cells  were washed 2x  with 
PBS and then fixed and stained in methanol containing 
0.05% orscein (J. T. Baker Chemical Co., Phillipsburg, 
N. J.) for 10 min. The plates were aspirated and glycerol 
was added (K. Knudsen, unpublished communication). 
All operations were performed at room temperature. 
Fusion was scored in  10  fields/plate along a  single 
diameter  using  a  phase  microscope  at  x  200.  In 
general, there were between 50  and  100  nuclei/field. 
The  number of nuclei in  myotubes, interacting cells, 
and single  cells was determined and  the results were 
expressed as a percent of the total nuclei present in the 
field. Each nucleus was counted only once, and hence 
the  sum  of  the  nuclei  in  myoblasts,  myotubes,  and 
interacting cells accounted for all the nuclei in the field. 
We operationally defined single cells, myotubes, and 
interacting cells as follows: Single cells are  discrete, 
individual  cells  that  contain  only  one  nucleus  and 
possess clear boundaries. Myotubes are cells containing 
two or more nuclei in a cluster or a line within a single 
cytoplasm. Interacting cells are those cells that are in 
close association with each other such that their bound- 
aries are  not distinguishable.  (Two  interacting myo- 
blasts are  scored as two interacting cells; a  myoblast 
interacting with a myotube is scored as one interacting 
cell .) 
The number of myotubes was estimated by scoring 
all individual myotubes within a field and any fractions 
of myotubes originating within the field but extending 
beyond it. 
The  percent fusion and number of nuclei and my- 
otubes per field are expressed as the mean with stan- 
dard deviation of the number of determinations shown 
by the integer in parentheses. 
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Fatty  acids  were  purchased  from  Nu  Chek  Prep 
(Elysian,  Minn.)  and  Applied  Science  Laboratories; 
fatty methyl esters, gas chromatography columns, phos- 
pholipid  standards,  thin-layer chromatography  plates, 
and BF~-methanoi reagent, from Applied Science Labo- 
ratories;  Lipopure  solvents  from  Burdick  &  Jackson 
Laboratories (Muskegon, Mich.); steroids  from  Stera- 
loids, Inc.  (Wilton, N.  H.);  media from  GIBCO  (or 
made from components purchased from Sigma); serum 
from  GIBCO  or  Flow Laboratories,  Inc.  (Rockville, 
Md.);  DME  from  Eastman Organic  Chemicals  Div., 
Eastman  Kodak  Co.  (Rochester,  N.  Y.);  ether  ana- 
logues of lecithin 2 from Calbiochem (San Diego, Calif.); 
and mevalonate, biotin, avidin, and other reagents from 
Sigma Chemical  Co. (St. Louis, Mo.). Phosphonylcho- 
line was a generous gift of T. Henderson (University of 
Illinois Medical School), and the phosphonate and phos- 
phinate analogues of lecithin,  s generous gifts of A. F. 
Rosenthal (Long Island Jewish-Hillside  Medical Center, 
New  Hyde  Park,  N.  Y.).  Tissue culture  plates  were 
manufactured by BioQuest, BBL  &  Falcon Products, 
Becton Dickinson & Co. (Cockeysville,  Md.) and Com- 
ing Glass Works, Science  Products Div. (Corning, N. 
Y.). The azido analogues of palmitate and stearate were 
synthesized  as described  by Chakrabarti and Khorana 
(9). 
Fatty acid and sterol stocks were made up in ethanol 
at concentrations such that  ---3 /~l (l_~) or -<7 /zl (pri- 
maries)  was  added  for  each  ml  of  growth  medium. 
Biotin was stored in ethanohH20 (1:1) at a concentra- 
tion of 0.5  mg/ml, and 3  /,d (for  Le) or 2.5  /zl (for 
primaries) was used for each ml of the growth medium. 
Other stocks  were made up in PBS at concentrations 
such that the volume added was <0.5% of the growth 
medium. The formulations of the buffers and reagents 
used for cell culture are given in Paul (42). All stock 
solutions were stored at  15~  and the fatty acid and 
cholesterol stocks were kept under argon. 
RESULTS 
Proliferation 
The proliferation of L8 grown under conditions 
used to alter the fatty acyl composition is shown 
in Fig. 1. The growth rate and saturation density 
of cells grown in LDM containing different fatty 
acids  and/or  biotin  depend  on  the  particular 
supplement. Cells grown without biotin or exog- 
z 1-octadec-9-enyl, 2-hexadecyl ether-DL-lecithin  and 
dihexadecyl ether-L-a-lecithin. 
3 Phosphonylcholine;  1,2-dipalmitoyl-sn-glycerol-3-(2'- 
trimethyl  ammoniumethyl)phosphate; and  DL-2-hexa- 
decoxy - 3-  octadecoxy - propyl  [2 - (trimethylammonium)- 
ethyl]phosphinate. 
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FIouRE  1  The  growth  of I.~ myoblasts in regular me- 
dium  (O)  and in LDMA  containing biotin  (1.5  #,g/m]) 
(A), oleate (12 #,g/ml) ([]), elaidate (12/~g/ml)  (@), or 
no additional supplement ( 0)'  The cells were plated at 
a concentration of 6  x  104 cells/5 ml. 
enous lipid do not proliferate appreciably. Of the 
fatty  acids tested,  septadecanoate,  oleate,  lino- 
leate, elaidate, linolenate, and azido derivatives 
of  stearate  and  palmitate  support  proliferation 
but to  different extents  (Table  I).  Oleate  gives 
the  fastest  growth  rate  and  highest  saturation 
density of the fatty acids tested, although it is less 
effective than biotin. Biotin and linoleate when 
supplemented together result in proliferation ex- 
ceeding  that  obtained  with  linoleate  or  biotin 
alone.  The  addition  of  biotin  to  the  cultures 
grown with some other fatty acids, e.g. elaidate, 
enhances their  proliferation as well,  but not to 
the  extent  observed  for  linoleate-biotin-supple- 
mented cells. Nonadecanoate, when used at sim- 
ilar concentrations, is toxic, but a twofold reduc- 
tion  in  concentration  does  support  significant 
proliferation. A  cyclopropane fatty acid (cis 9,10 
methylene  octadecanoic  acid)  is  either  toxic  or 
supports  no  net  proliferation  through  day  4, 
depending on  the  concentration used;  in some 
experiments, cell doubling commenced after 4-5 
days. In addition to fatty acids and biotin, dipal- 
mitoyllecithin  supports  proliferation;  however, 
ether analogues" of lecithin do not, unless biotin 
or fatty acid is present (Table I). 
We have attempted to maintain cultures of L6 
grown  on  LDMA  containing fatty  acid  and/or 
biotin through multiple subculturings (Table II). 
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Growth of Le Myoblasts in Medium Containing Fatty Acid and Polar Headgroup Supplements 
Medium supplement  Cells/cm 2 (day 4)  Medium supplement  Cells/em i (day 4) 
Regular medium (3)  7.0 +-- 2.1  x  10  ~ 
LDMA (17)  5.6 -  1.8 x  10  a 
LDMA + : 
Biotin (1.5 v.g/ml) (21)  4.6 _  1.4 x  10' 
Heptadecanoate (4.2/zg/ml) (3)  4.0 _  0.5  x  104 
Heptadecanoate (8.3/zg/ml) (3)  3.0 -  1.5  x  10  4 
Stearate (8.3 /~g/ml) (2)  3.5 -  0.8 x  104 
6-azido Stearate (8.3 #g/ml) (3)  1.5  -  0.3 x  104 
9-azido Stearate (8.3/~g/ml) (3)  2.5 -  0.2  x  104 
12-azido  Stearate  (8.3  v.g/ml)  2.1  +_- 0.5  x  104 
(3) 
9-azido  Palmitate  (8.3  /,g/ml)  1.4 -  0.1  x  104 
(3) 
Elaidate (8.3 ~g/ml) (2)  2.4 -  0.5  x  104 
Elaidate  (8.3  /zg/ml)  +  biotin  3.8-4--0.5  x  104 
(1.5 ~g/ml) (4) 
Linoleate (8.3 ~g/ml) (4)  2.3 +- 0.6 x  104 
Linoleate (8.3  /~g/mi)  +  biotin  5.2 +- 1.4 x  104 
(1.5  /~g/ml) (4) 
Linolenate (8.3 p,g/ml) (2)  1.7 -+ 0.1  x  104 
Nonadecanoate (4.2/~g/ml) (3)  1.4 +_ 0.2 x  104 
Dihexadeeylether-lecithin  (20  4.9 +- 2.2 x  10  a 
/.~g/ml) (3) 
Dihexadecylether-lecithin  (20  2.1  +- 1.2  x  104 
/~g/ml)  +  biotin  (1.5  ~g/ml) 
(3) 
Dihexadecylether-lecithin  (20 
v,g/ml) +  oleate (12.5  t~g/ml) 
(2) 
2.1  -0.8  x  10  ~ 
Octadecenyl, hexadecylether- 
lecithin (20/.~g,/mi) (3) 
Octadecenyl, hexadecylether- 
lecithin  (20  v.g/ml)  +  biotin 
(1.5  /zg/ml) (3) 
Octadecenyl, hexadecylether- 
lecithin  (20  /~,g/ml) +  oleate 
(12.5/.~g/ml)  (2) 
LDMB + : 
Dipalrnitoylphosphonylcholine 
(20 v,g/ml) (4)* 
Dipalmitoylphosphonylcholine 
(20  g,g/ml)  +  choline (4 p,g/ 
ml) (2)* 
Hexadecoxy,  octadecoxypro- 
pylphosphinate  (20  ~g/ml) 
(2)* 
Phosphonyleholine  (8  p,g/ml) 
(4)* 
Phosphonyleholine (8 ~g/ml) + 
choline (4/~g/ml) (2)* 
DME (4 ~g/ml) (2)* 
LDMA +: 
Dipalmitoylphosphatidylcholine 
(8.3/~g/ml) (2) 
Egg lecithin (8.3/~g/ml) (2) 
Cis-methyleneoctadecanoate 
(12.5 ~g/ml) (2) 
5.1  _+2.6x  10  a 
1.0-+ 0.4 x  104 
1.7_+0.5  x  104 
1.7_  0.5  x  104 
5.5-+ 2.3  x  104 
1.3  +__0.6￿  104 
1.3-0.2  x  104 
5.7-+  1.0 x  104 
2.5-  0.1  x  104 
1.3  +- 0.1  x  104 
1.7-+0.3  x  104 
5.0-0.8  x  10  a 
L6 cultures were plated at a concentration of 6 x  104 cells/5 ml and counted on day 4. 
* For these experiments, choline was not present in the LDM unless specifically  indicated. 
Oleate-supplemented  cells  can  be  subcultured, 
but proliferation decreases substantially.  If stear- 
ate or biotin is added  to these  arrested cultures, 
proliferation  resumes.  Biotin-,  stearate-oleate-, 
and  linoleate-biotin-supplemented  cultures  con- 
tinue to proliferate  at normal  rates through  sev- 
eral  subculturings.  Attempts  to  maintain  long- 
term  cultures  of L6 on  septadecanoate  are  con- 
sistently  successful  only  when  subculturing  is 
done at higher cell densities. 
The  supplementation  of LDMB  with  25-OH 
cholesterol has a  marked,  dose-dependent  effect 
on L6 proliferation. The data presented in Fig. 2 
show  that  proliferation  is  inhibited  when  the 
amount  of inhibitor  approaches  or  exceeds  0.1 
/~g/ml. A  marked change in cellular morphology 
accompanies  the proliferative inhibitions.  When 
viewed  in  the  phase-contrast  microscope,  the 
cells  appear  less  spread  out  and  triangular  in 
shape.  These  effects  of  25-OH  cholesterol  on 
proliferation  and  morphology  are  reversed  by 
the  addition  of  cholesterol  or  mevalonate  (the 
end  product  of the  inhibited  pathway  and  reac- 
tion,  respectively  [12])  and  are  prevented  by 
the  inclusion  of  these  compounds  at  the  time 
of plating  (Fig.  2).  Desmosterol,  an  analogue  of 
cholesterol,  was  also  tested  for  its  ability  to 
support  the  proliferation  of  L~  grown  in  the 
presence of 25-OH cholesterol. The inclusion of 
desmosterol  results  in cell densities comparable 
to  those  of  cholesterol-supplemented  cells.  1-,6 
grown  in  LDMB  containing  25-OH  cholesterol 
and  mevalonate  or  desmosterol  proliferate  at 
nearly normal rates through several subculturings 
(Table II). 
When  grown  in  LDM,  L6  displays  a  choline 
requirement  for growth  (Fig.  3).  In  addition  to 
choline, lecithin and DME support proliferation, 
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Long- Term Culture of Le Myoblasts 
Medium supplement  Pass 1  Pass 2  Pass 3 
Cells/cm 2  Cells/cm 2  Cells/cm 2 
A* 
LDMA +  biotin (1.5/~g/ml) (5)  3.0 -+  1.2  x  104  4.4 -+  1.2 x  104  4.7 -+ 2.1  x  104 
LDMA +  oleate (8.3/zg/ml) (3)  2.9 -+  1.0 x  104  4.7 -+ 2.2 x  103  3.9 -+ 1.4 x  103 
To  stearate (4.2  /zg/ml)-oleate (4.2  /Lg/  -  -  1.6 _+ 0.3  x  104 
ml) (3)* 
To biotin (I .5 tzg/ml) (3)* 
LDMA  +  linoleate  (8.3  ~g/ml)  +  biotin 
(1,5 p.g/ml) (2) 
Bw 
LDMA 
LDMA +  biotin (1.5 v.g/ml) (2) 
LDMA  +  stearate  (4.2  p.g/ml)  +  oleate 
(4.2 p.g/ml) (2) 
LDMA +  septadecanoate (4.2 p.g/ml) (2) 
LDMB  +  25-OH  cholesterol  (0.1  /~g/ml) 
+  mevalonate (1 mg/ml) (2) 
LDMB  +  25-OH cholesterol  (0.1  p.g/ml) 
+  desmosterol (2 p.g/ml) (2) 
-  -  2.1  -+ 1.3 x  104 
2.9 _+ 2.0 x  104  8.3 +  0.4 x  104  8.1  -+ 1.6 x  104 
6.8 -+  1.6 x  10  a  5.8 -+ 0.3  x  103  7.3 -+ 2.4 x  103 
4.9 _+ 0.1  x  104  2.8 -+ 0.1  x  104  9.0 --- 0.0 x  104 
5.4 --_ 0.6  x  104  2.8 -+ 0.2  x  104  3.7 -+ 2.5  x  104 
4.0 _+ 0.7 x  104  2.0 -+ 1.1  x  104  2.6 -+ 0.0 x  104 
4.4  x  104 , 4.8  x  10411  3.7 -+ 0.7 x  104  5.2 -+ 0.8  x  104 
3.2  x  104 , 5.7  x  10411  2.5-~ 0.1  x  104  4.6 -4- 1.6 x  104 
* The cells were initially plated and subsequently subcultured at a  concentration of 6  x  10  4 cells/5 ml every 4-5 
days; the values presented are the cell densities at the time of subculturing. 
* I_~ was plated and subcultured in oleate-supplemented LDMA, and, after the second pass, replated into LDMA 
supplemented with stearate and oleate. 
w The cells were initially plated and subsequently subcultured at a concentration of 6  x  10  4 and 1  x  10  5 cells/5 ml, 
respectively. The values presented are the cell densities at the time of subculturing. 
II In this experiment, I~ was initially plated at 6  x  10  4 and I  x  10  z cells/5 ml and both values are presented here; the 
first corresponds to cells plated at the lower density. 
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FIGURE  2  (A) The growth of Le myoblasts in LDMB (O) and in LDMB containing 25-OH cholesterol- 
0.06 p.g/ml (A), 0.1/zg/ml (V), or 0.3 p.g/ml (&). The arrow shows the time at which mevalonate (1 mg/ 
ml) (0)  or cholesterol  (2  /~g/ml) (0)  was added to the cultures growing in LDMB containing 25-OH 
cholesterol (0.1  p~g/ml).  The cells were plated at a concentration of 6  x  104 cells/5 ml. (B) The growth of 
L6 myoblasts in  LDMB  (O),  in  LDMB  containing 0.1  p.g/ml 25-OH  cholesterol  (A),  and  in  LDMB 
containing 25-OH cholesterol (0.1  ~.g/ml) and cholesterol-1  /~g/ml (El), 2  p.g/ml (~) or mevalonate- 
100/~g/ml (&),  1 mg/ml (0). The cells were plated at a concentration of 6  x  104 cells/5 ml. 
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FIGURE 3  The  growth  of L~ myoblasts  in  LDMB  (4 
/~g/ml choline)  (￿9  choline-free  LDMB  (@), and  in 
choline-free LDMB containing ethanolamine-2 p,g/ml 
(El), 20/~g/ml (I). The arrow shows the time at which 
exogenous choline (4/~g/ml) (A) was added to cultures 
growing in LDMB containing 20 p,g/ml ethanolamine. 
The cells were  plated at a concentration of 6  x  104 
cells/5 ml. 
whereas a  phosphonate analogue of choline and 
phosphonate and phosphinate analogues  a of lec- 
ithin do not  (at comparable concentrations) un- 
less choline  is present  (Table  I).  We  have  also 
studied  the  growth  of L6  in  LDMB  containing 
ethanolamine since it can  be used to synthesize 
PE,  a  principal,  natural  phospholipid found  in 
these  cells.  As  shown  in  Figs.  3  and  4,  low 
concentrations of ethanolamine produce little or 
no  further  effect  on  proliferation compared  to 
that  of  cells  grown  in  choline-free  LDMB, 
whereas at relatively higher concentrations there 
are changes in morphology as well as a decrease 
in  proliferation  (or  attachment  to  the  substra- 
tum).  Even  when  grown  in  the  presence  of 
relatively high amounts of ethanolamine, a  sub- 
stantial fraction of the  cells remains viable and 
rapidly grows  to  confluence  upon  addition  of 
choline (Fig. 3). L~ grown in choline-free LDMB 
containing DME does not proliferate appreciably 
after subculturing (data not shown). 
Primary Lipid Alterations 
Table  III contains  fatty  acyl  analyses  of the 
phospholipids  present  in  L6  grown  in  regular 
medium and in LDMA containing the indicated 
supplements and  analyzed on  day 4,  There  are 
only  small  differences  between  the  fatty  acyl 
composition of cells grown  in  regular medium, 
LDMA  containing  biotin,  and  LDMA  without 
biotin.  These  occur  mostly  in  the  amounts  of 
16:1  and  18:1  and  result  in  changes  in  the 
proportion of 16- and  18-carbon fatty acids but 
maintain a  normal fraction of unsaturated  fatty 
acids.  L~  grown  in  LDMA  (no  biotin)  supple- 
mented with select fatty acids displays fatty acyl 
compositions reflecting the  supplement  and  its 
metabolic  derivatives.  In  cells grown  in  septa- 
decanoate-supplemented  media,  for  example, 
17:0 and  17:1  occupies -45%  of the total. This 
enrichment results only in a small change in the 
fraction  of  unsaturated  fatty  acyl  chains  com- 
pared to that of the control (regular medium) or 
biotin-supplemented  cultures.  Both  the  nona- 
decanoate-  and  septadecanoate-derived enrich- 
ments  occur  primarily at  the  expense  of both 
stearate  and  palmitate  and  their  mono-unsatu- 
rated derivatives. The  resulting ratio of 16-car- 
bon fatty acids to 18-carbon fatty acids increases 
almost twofold. 
Supplementation with unsaturated  lipids pro- 
duces  an  enrichment  in  the  supplements  and 
their metabolic derivatives in  the  cellular phos- 
pholipids and  produces large  increases  in  both 
the fraction of unsaturated fatty acyl chains and 
the fraction of 18-carbon fatty acids. In oleate- 
supplemented  L~,  up  to  75%  of  its  fatty  acyl 
positions  are  occupied  by  oleate.  There  is  no 
indication of appreciable further metabolism into 
longer or polyunsaturated fatty acid. In linoleate- 
and  elaidate-supplemented cells,  -55%  of the 
fatty acyl positions are occupied by linoleate and 
arachidonate,  and  65-80%  by elaidate, respec- 
tively. These enrichments are accompanied by a 
parallel decrease  in  oleate and  produce  a  large 
decrease in  the ratio of 16-carbon to  18-carbon 
fatty acids. The supplementation of LDMA con- 
taining linoleate or elaidate with biotin somewhat 
lowers the extent of exogenous fatty acid incor- 
poration and shifts the ratio of 18:2/20:4 derived 
fatty acyl chains to favor 20:4.  In the  range  of 
fatty acid concentrations  used  for these  experi- 
ments, there is little, if any, dose dependence on 
the  resultant  incorporation  of  oleate  and  elai- 
date.  Using  NMR  and  IR,  we  have  obtained 
evidence  for incorporation  of  12-azido  stearate 
into  phospholipids (data  not  shown).  Attempts 
to  enrich  L6  with  linolenate  were  not  always 
successful. In three attempts, two were successful 
and showed incorporation of 18:3 and its metab- 
olism to 20:5; these data are presented in Table 
III. 
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Fatty Acyl Alterations  in Myogenic  Cells 
Fatty acyl composition (% by weight) 
Medium supplement  14:0  16:0  16:1  17:0  17:1  18:0 
Regular Medium 
L~ (3)  1.8 -* 0.5  24.1 __ 2.3  10.1  •  2.7  -  19.6 •  2.6 
PMB (2)  2.2 -+ 0.7  34.9 _+ 0.6  2,6 _+  1.1  -  -  31.4 •  6.7 
PMT (3)  1.2 -+ 0.2  25.3 _+ 5.0  4,2 _+  1.4  -  -  24.1 -- 3.6 
PPT (2)  1.0 +- 0.0  21.4_+2.0  5,2_+0.8  -  -  25.9_+0.5 
LDMA 
Ls(4)  7.6-+1.5  22.1-'2.3  21,9-+4.8  -  14.0-+3.1 
PMB (2)  0.8 -+ 0.2  19.6 •  1.2  6.8 .+ 0.2  -  -  20.5 -+ 0.2 
PMT (2)  1.3 •  0.8  23.9 •  7.2  10.4 -+  1.4  -  -  16.0 -+ 0.3 
PPT (2)  3.5 -+ 0.1  28.4 -+ 6.5  6.8 _+ 6.1  -  -  24.9 -+  3.3 
LDMA +  biotin 
(1.5/zg/ml) Ls (5)  2.1 -+ 0.2  22.6 •  4.9  12.0 _+ 2.3  -  -  17.3 _+  2.3 
)PMB (2)  0.7•  18.3_+1.2  6.5-+1.4  -  -  20.7-3.7 
(1.25/.~g/ml)~PMT (2)  1.4 -+ 0.4  29.0 _+  1.6  4.6 _+ 0.2  -  -  20.8 -+  1.9 
"PPT (2)  1.1•  17.7•  12.7_+0.7  -  20.3_+2.1 
LDMA +  heptadeeanoate 
(8.3/~g/ml) Le (2)  2.4 -+ 0.6  6.1 .+  1.3  5.2 -+ 0.8  22.4 -+ 2.7  49.5 _+ 0.4  3.5 -+ 0,3 
_  .,]PMB (2)  0.9 •  0.5  7.9 •  2.6  5,4 •  1.5  23.2 •  0.9  29.5 •  2.9  6.4 -  0,9 
(5.2/zg/mll~pM  T  (2)  1.1  .+ 0.3  12.4 -+  0.5  5.9 -+  1.0  22.3 -+ 0.7  29.5 •  3.7  7.6 _+ 0,2 
(10.4 ~,g/ml) PIT (3)  1.5 _+  1.3  9.6 •  1.2  6.0 •  1.0  29.9 _+  10.6  23.3 _+ 5.0  8.6 •  2.4 
LDMA +  nonadecanoate 
(4.2/~g/ml) L~ (3)  3.3 •  1.4  13.0 =  7.3  6.9 •  0.3  2.1 _+ 0.8  4.3 .+  1.9  5.8 •  3.7 
(5.2 p,g/ml) PMT (2)  1.2•  11.9 .+  1.1  5.6_+0.5  2.0•  2.9_+0.1  4.5-*0.5 
LDMA +  oleate 
(8.3/.~g/ml) L0 (3)  3.3 _+ 0.7  9.3 -*  1.1  5.3 .+  1.5  -  -  6.6 -*  1.6 
(16.7/zg/ml) L6 (2)  2.1  -*  0.0  8.9 _+  2.2  4.6 .+ 0.9  -  7.1 •  0.8 
PMB (2)  1.0 .+ 0.1  17.7.+5.5  2.4_+0.9  -  IL6.+  1.1 
(10.4/zg/ml)  PMT (2)  1.1.+0.1  16.9_+1.2  2.0_+0.2  -  9.3.+1.1 
(62.5/zg/ml) FFT (2)  1.2 _+  1.0  12.2 _+  9.1  2.0 _+ 0.5  -  -  11.2 .+ 5.9 
LDMA +  elaidate 
(8.3/~g/ml) L~ (3)  2.9 -+ 2.3  5.7 .+ 2.3  10.3 _+ 4.4  -  2.2 .+ 0.9 
(16,7 p,g/ml) La (2)  1.4 _+ 0.7  3.8 .+  1.0  3.3 -+  2.0  -  -  2.1  -+ 0.3 
,  r)PMB (2)  -  4.0 •  1.0  2.7 •  1.5  -  2.8 -+ 0.3 
(10.4 ~g/ml) 
JPMT (2)  0.4 -+ 0.2  4.7 •  2.8  7.5 _+  3.1  -  -  1.8 -+  0.5 
(62.5 p,g/ml) PPT (2)  -  4.1 •  0.6  3.9 •  0.8  -  3.1  -* 0.5 
LDMA +  biotin (1.5/~g/ml) +  elaidate (8.3 p,g/ml) 
l.,s (2)  1.9 .+ 0.1  12.5 •  1.3  10.9 .+ 2.9  -  7.3 _+ 0.9 
LDMA +  linoleate 
(8.3 ~.g/ml) La (2)  4.1  _+  1.3  21.9 _+  2.1  1.5 -+ 0.3  -  10.0 •  0.2 
LDMA +  biotin (1.5 ~g/ml) +  linoleate (8.3 /zg/ml) 
L~ (4)  3.2 .+ 0.3  25.1  _+ 4.3  3.3 .+ 0.9  -  -  24.9 •  1.1 
LDMA +  linolenate 
(8.3 ~g/ml) L~ (2)  4.5 •  1.3  19.3 -+ 0.5  2.4 _+ 0.0  -  15.5 _+ 9.4 
L6 myoblasts were plated at a concentration of 1.8 x  106 cells/15 ml and harvested for analysis on day 4. Primary myoblasts (PMB), myotubes (PMT), and 
preformed tubes (PPT) were plated at a concentration of 4  x  108 cells/16 ml. The primary preformed myotubes were formed by growing the expinnted cells 
in LDMA for 3 days, at which time the stated additions were made; the cells were harvested for analysis on day 5 (457 h after the additions). 
The  fatty  acyl  analyses  of  L6  cultures  grown 
through  several subcultures  on LDM  containing 
biotin or fatty  acids are presented  in Table  IV. 
When compared to the control or cells grown in 
biotin-supplemented  LDM,  long-term  cultures 
supplemented  with  oleate  or  stearate-oleate 
(1:1)  show  a  continued,  marked enrichment  in 
oleate  and  in  the  fraction  of  unsaturated  fatty 
acids. However, at early times, the enrichment is 
somewhat  larger  than  at  the  later  times.  In 
septadecanoate-supplemented  cultures,  the  ex- 
tent  of  enrichment  also  does  not  increase  with 
subsequent  subculturing.  In  stearate-oleate- 
(1:1) supplemented cells,  there  is little,  if any, 
net enrichment in stearate. 
Though not studied  in comparable detail, pri- 
mary  explants  of chick  pectoral  muscle  grown 
under similar  conditions show fatty acyl compo- 
sitions  analogous to those just  described  for L6 
(Table  III). Three types of primary muscle  cul- 
ture  were  studied:  myoblasts,  prepared  by 
growth  in  low  calcium  media;  myotubes,  pre- 
pared by growth in a medium containing normal 
calcium  levels;  and  preformed  myotubes,  pre- 
pared by allowing myotubes to form before fatty 
acyl  supplementation.  The  myoblasts grown in 
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Fatty  acyl composition  (% by weight) 
18:1c  18:1t  18:2  18:3  19:0  19:1  20:4  20:5 
%  Un-  Double 
saturated  16c/18c  bonds 
35.5  •  0.9  --  2.2 •  0.5  --  --  --  6.8  •  1.4 
20.2 •  2.3  --  3.5  •  0.3  --  -  --  5.3 •  2.2 
31.1  •  7.1  --  3.0 •  1.9  --  --  --  11.1  •  2.8 
30.6 •  1.6  --  2.5 •  0.1  --  --  --  13.3 •  3.3 
28.7 •  1.5  .....  5.6  •  1.9 
42.3 +-  1,0  --  2.4  •  0.0  -  -  -  7.7 •  0.1 
40.0 •  9.1  --  2.0 •  0,3  -  -  -  6.0  -+  0.0 
31.8 •  0.5  -  1,3 •  1.8  -  -  -  3.3 •  2.4 
42.3  •  7.8  .....  3.6 •  2.7 
43.4  •  3,1  -  2.6 •  0.1  -  -  -  7.6 •  0.2 
27.1  •  3,5  -  4.5  •  0,8  -  -  -  12,6 •  0.5 
41.7 -+  0,6  .....  6.5 •  1.0 
9.6 -  1.9  .....  1.2  -+  1,8 
14.5 -  0,2  -  2.4 •  0,2  -  -  -  9.9 -+  1.4 
16.1  -+  0.8  .....  5.1  •  2.7 
15.2 -  8.7  .....  13,4 •  11.6 
t6.0  •  3.9  -  -  -  21.5  •  2.3  24.0 •  8.0  2.9 •  2.6 
16.6 •  0,8  -  -  -  18,3  •  0.3  29,9  •  2.0  7.1  +-  1.2 
73,0 •  1.9  .....  2.5  •  0.3 
76.3 •  1.1  .....  1.1  •  1.5 
62.1  •  6.6  .....  5.1  -+  1.1 
67,2 •  0.3  .....  3.5  -+  0.7 
70.0 --  8.1  -  2.8 •  3.9  --  -  --  1.6 •  2.3 
13.4 •  4.4  65.5  •  13.8  .... 
7.4 •  2.4  81.9  •  3.8  .... 
11.2•  1.4  79.3•  1.6  .... 
13.5 •  2.3  72.1  -+  9.0  .... 
11.3 •  0.2  77.6 •  0.0  .... 
24.6 •  1.5  42.4  •  1.4  0.4 •  0.6  -  -  - 
6,7 •  0.1  --  43.8 -+  1.8  -  -  12.0 •  1.5 
9.2  •  1,6  -  13.7 •  7.4  -  -  20,7  •  6,1 
6.7 •  2.5  -  -  17.7 --  10.6  --  --  7.6 •  3.7  26.1  •  4.4 
54.6  0.60  77.2 
31.6  0.68  51.0 
49.4  0.51  85.7 
51.6  0.45  94.0 
56.2  1.03  73 
59.2  0.40  84.7 
58.4  0.58  78.4 
43.2  0.58  54.4 
58.1  0.58  68.9 
60.1  0.37  85.5 
48.8  0.64  91.1 
60.9  0.49  80.4 
65.5  0.86  69.1 
61.7  0.57  93.8 
56.6  0.77  71.9 
57.9  0.66  98.1 
54.1  0.91  62.8 
62.1  0.83  83.4 
80.8  0.18  88.3 
82.0  0.16  85.3 
69.6  0.27  84.9 
72.7  0.25  83.2 
76.4  0.17  84.0 
89.2  0.20  89.2 
92.6  0.08  92.6 
93.2  0.07  93.2 
93.1  0.14  93.1 
92.8  0.09  92.8 
78.3  0.31  78.7 
64.0  0.39  143.8 
46.9  0.59  122.7 
60.5  0,54  223,1 
control  media have  a  somewhat  more saturated 
fatty acyl composition than does L0 and the other 
primary  cell  types.  This  arises  primarily  from 
differences  in the amounts of 16:0  and  18:1.  In 
cells grown in oleate-supplemented media, oleate 
occupies between  62  and  70%  of the  fatty  acyl 
positions.  Supplementation  with elaidate  results 
in  72-77%  of the  acyl positions being  occupied 
by elaidate.  This  enrichment is accompanied by 
a  marked decrease in relative amount of oleate. 
In  both  oleate-  and  elaidate-enriched  cells,  the 
fraction of saturated  fatty  acids and the ratio of 
16-  to  18-carbon  fatty  acids  decreases.  In  my- 
otube  cultures  produced  by  fusion  of  elaidate- 
enriched myoblasts, a substantial fraction of my- 
oblasts are present along with the myotubes (see 
Fusion section below). 
Evidence  for  the  incorporation  of  fatty  acid 
supplements  into  a  plasma  membrane  prepara- 
tion of Le is presented in Table  V. 4 The  plasma 
4 Using the fractionation procedure of Schimmel et al. 
(40),  we  also  find  plasma  membrane  enrichments  in 
elaidate- and oleate-supplemented  chick myotube cul- 
tures comparable  to those observed in analyses of the 
total cellular phospholipids. After 3 days in culture and 
starting at an initial cell density of 0.5  ￿  106 cells/ml, 
plasma  membranes  from  control cultures (regular fetal 
calf serum) have 26.6 -+ 2.9%  (three determinations) of 
their fatty acyl positions occupied  by oleate.  In oleate- 
(10  /~g/ml) supplemented  cultures,  this value increases 
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Fatty Acyl Alterations in Long-Term Myoblast Cultures 
Medium supple- 
ment  Fatty acyl composition ( % by weight ) 
LDMA +  biotin (1.5 ~,g/ml)* 
%  16c/  Double 
Pass no.  14:0  16:0  16:1  18.0  18:1  Unsat.  18c  bonds 
1 (3)  2.1  •  0.8  23.8 -+ 4.9  7.6 -+  2.2  22.0 -+  7.4  44.4 -+ 5.4  52.0  0.47  52.0 
2 (2)  2.2 -+ 0.8  18.6 -+ 0.1  7.3 -+ 0.0  21.9 -+ 0.9  49.2 -+  1.1  56.5  0.36  56.5 
3 (5)  2.4 -+ 0.4  25,0 -+ 4.1  8.3 -+ 2.0  19.0 -+ 4.9  45.0 -+ 3.8  53.3  0.52  53.3 
4 (2)  2.1  •  0.6  24.7 -+ 4.7  7.9 -+ 0.3  23.9 -+  1.0  41.3 -+  5.9  49.2  0.50  49.2 
5 (2)  3.1  -+  1.3  28.8 +- 9.5  6.9 •  2.3  24.9 -+ 5.6  35.6 •  13.4  42.5  0.59  42.5 
LDMA +  oleate (8.3 t~g/ml)* 
Pass no.  14:0  16:0  16:1  18:0  18:1  18:2  20:4 
%  16c/  Double 
Unsat.  18c  bonds 
1 (2)  4.6 -+  1.8  13.1 -+  2.5  4.2 -+  1.0  6.5 +-  1.5  71.7 •  4.0  -  75.9  0.22  75.9 
2 (2)  3.9 •  1.3  14.2 -+  1.4  5.2 -+  0.8  8.5 +-  1.6  65.7 -+ 8.5  1.2 -+  0.3  2.2 -+  1.7  74.3  0.26  82.1 
3 (2)  6.1  -+  1.2  20.6 -+  3.2  6.7 •  0.9  10.1  •  1.6  54.3 -+  1.5  2.9 •  0.1  -  63.9  0.41  66.8 
LDMA +  stearate (4.2 /~g/ml)  +  oleate (4.2/~g/mll~t 
% 
Pass no.  14:0  16:0  16:1  18:0  18:1  20:4  Unsat. 
16c/  Double 
18c  bonds 
1 (3)  2.6 -+ 0.5  5.8 -+  1.7  4.2 -+ 0.1  24.7 -+ 3.0  61.4 -*  3.1  2.0 •  0.3  67.6 
3(2)  4.4-+1.8  11.3+-6.4  5.3•  26.3-+17.8  52.5•  57.8 
LDMA +  septadecanoate (4,2 V,g]ml)r 
Pass no.  14:0  16:0  16:1  17:0  17:1  18:0  18:1 
0.I2  73.6 
0.21  57.8 
%  16c/  Double 
Unsat.  18c  bonds 
3 (2)  6.8 •  1.7  26.0 -+ 4.7  6.6 -+ 0.1  14.5 -+  3.2  21.0 -+ 4.7  12.6 •  0.8  12.3 -+  3.9  39.9  1.31  39.9 
LDMA +  septadecanoate (8.3 ~g/ml)$ 
%  16c/  Double 
Pass no.  14:0  16:0  16:1  17:0  17:1  18:0  18:1  Unsat.  18c  bonds 
3 (2)  4.5 -+ 2.1  17.0 +- 7.4  5.4 •  0.6  20.7 -+ 4.4  33.3 •  15.2  8.4 -+  1.2  10.5 -+ 0.6  49.2  1.19  49.2 
5(2)  4.2•  20.0-+0.9  5.5-+0.6  18.0-+10.5  33.0-+3.3  7.8-+0.6  11.2-+4.4  49.7  1.34  49.7 
LDMA +  linoleate (8.3 /.~g/ml) +  biotin (1.5 v,g/ml)*  %  16c/  Double 
Pass no.  14:0  16:0  16:1  18:0  18:1  18:2  20:4  Unsat.  18c  bonds 
1(2)  3.0•  31.1-+10.9  2.9•  25.9-+0.4  13.3•  6.8-+6.8  16.9•  39.9  0.74  97.4 
2 (2)  2.5 •  0.1  29.5 •  2.8  3.5 -+  0.7  23.3 -+ 2.1  20.0 -+  8.0  5.3 •  0.4  15.7 -+ 3.4  44.5  0.68  96.9 
3(2)  3.1-+1.1  35.1+-14.7  3.7•  23.2-+1.4  20.1-+11.5  4.1-+0.4  10.6+-3.5  38.5  0.82  74.4 
I~ cultures were plated at a concentration of 6  x  104 cells/5 ml and subcultured at a concentration of 6  ￿  104 (~  or 1 ￿  10  s (:~) cells/5 ml every 4-5 days. At 
the time of subculturing an aliquot was removed for analysis. 
membrane preparation  was described  previously 
for this cell type,  and our  morphologic  observa- 
tions  (unpublished)  are  in  accord  (8).  Supple- 
menting  the  growth  medium  (LDMA)  with 
oleate  or elaidate  produces  clear enrichments  of 
oleate  and  elaidate,  respectively,  in  the  plasma 
membrane  lipids.  The  variability,  however,  is 
large.  In  contrast,  linoleate-,  linoleate-biotin-, 
to 74.4  -+ 2.8% (three  determinations), and in elaidate- 
(10/.~g/ml) supplemented cultures  it decreases  to 5.8  -+ 
2.8%  and is  replaced  by elaidate-84.4  ___ 2.4%  (two 
determinations).  In  a  single  experiment,  we  saw  no 
significant  effect of the presence of biotin on the extent 
of elaidate  enrichment  (W.  T.  Krussman and A.  Hor- 
witz, unpublished observations). 
and  elaidate-biotin-supplemented  cultures  are 
relatively less enriched. 
The growth  of L6 under conditions  reported  to 
inhibit sterol synthesis results in a decrease  in the 
level of cellular  sterol.  Analyses  of the  levels  of 
cellular-free  sterol presented  in Table VI show a 
small  diminution  resulting  from  the  shift  from 
regular  media  to  LDMB  and an  additional  two- 
fold  decrease  when grown  in LDMB  containing 
25-OH  cholesterol.  Comparable  or  somewhat 
larger  changes  are  seen  when  the  sterol  level  is 
normalized  to  phospholipid  rather  than protein. 
This  decrease  in  sterol  appears  to  be  the  mini- 
mum attainable  with this protocol,  since increas- 
ing  the  amounts  of  inhibitor  or  decreasing  the 
density  of  the  cells  does  not  produce  a  further 
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LDMB containing 25-OH cholesterol and meva- 
lonate or cholesterol is between that of inhibited 
and  that  of  control  (uninhibited)  cells  (Table 
VI).  This  lowered level  is  maintained  through 
five  passages.  We  point  out  that  the  levels of 
inhibitor used  in  these  studies  are only a  small 
fraction  (-1%)  of the  total  cellular sterol.  In 
general,  L6  when  grown  in  LDM  has  variable 
amounts of desmosterol, the  immediate precur- 
sor of cholesterol, and no detectable cholesterol 
esters contributing to the total sterol. 
We  have  tried  to  replace  cholesterol  with 
sitosterol or desmosterol using this method  and 
to increase the level of cholesterol by increasing 
the amount of exogenous cholesterol added. We 
see only slight incorporation of sitosterol at the 
concentration assayed. The  desmosterol level of 
L6 grown  in  LDMB  supplemented with  25-OH 
cholesterol and  desmosterol is the same as that 
of cells grown  in  LDMB  alone.  However,  the 
cholesterol  level  is  lower,  approaching  that  of 
the  inhibited cells.  These  sterol  levels are  still 
observed after five subculturings in  the desmos- 
terol-containing media. We do find that increas- 
ing the  amount  of external cholesterol does in- 
crease the  level of both cholesterol and choles- 
teryl  esters;  however,  the  possible  uptake  of 
"microcrystals" of cholesterol has not been  ex- 
cluded (data not shown). 
Analogous changes are seen in myogenic cells 
derived from  primary explants. These  data  are 
also  presented  in  Table  VI.  In  primary  chick 
myoblasts, the initial sterol level (normalized to 
protein) is lower than that of L6, and decreases 
-25%  to a  value similar to that of L~ grown in 
the presence of 25-OH cholesterol. The level of 
cellular sterol in primary myotubes is higher than 
that  of  L6  or  primary  myoblasts.  It  decreases 
approx, twofold when 0.63 ~g/ml 25-OH choles- 
terol is added to the  growth medium  (LDMB). 
Higher concentrations of 25-OH cholesterol are 
lethal. 
The  analyses of the  membrane  phosphatides 
presented in Table VII show that the ratio of PE/ 
PC  changes  with  alterations in  the  growth  me- 
dium.  When  L~ is grown  in  choline-free LDM, 
the ratio of PE/PC  increases twofold from 0.70 
to  1.44.  The  presence of low concentrations of 
ethanolamine  produces  little  further  change  in 
this ratio, whereas at higher concentrations the 
ratio increases. This increase appears to parallel 
roughly the effect of ethanolamine on prolifera- 
tion (or attachment to the substratum) (Fig. 4). 
The  sum  of  PE  and  PC  always  accounts  for 
-80%  of the  total phospholipid; the remaining 
20%  is  divided equally  between  sphingomyelin 
(Sph) and phosphatidylserine (PS) and phosphati- 
dylinositol (PI). We are unable to detect apprecia- 
ble amounts of phospholipid derived from either 
DME  or monomethylethanolamine in  these cells 
or large secondary changes in the other phospho- 
lipid  classes  except  perhaps  for  Sph  (data  not 
shown).  When LG is grown in LDM lacking cho- 
line  and  containing  DME  under  the  conditions 
described, the phospholipids derived from  it oc- 
cupy -55%  of the total membrane phospholipid. 
In contrast to these enrichments, the growth of L6 
(or  primary  myoblasts)  in  a  100-fold  excess  of 
choline produces no significant change in the PE/ 
PC ratio compared to that of the control. 
Supplementing the growth medium of primary 
cells with  ethanolamine  or  DME  produces en- 
richments comparable to those just described for 
L6.  In  primary myotubes grown  in  regular me- 
dium  a  larger fraction of their phospholipids is 
derived from choline than in L~ (60% in primar- 
ies vs.  44%  in LB). This accounts for the some- 
what lower initial PE/PC ratio of 0.53 (compared 
to  0.70  in  L6);  this  relative  increase  in  PE  is 
accompanied  by  lower levels of PS  and/or  PI, 
with little change in Sph.  The  addition of etha- 
nolamine to the growth medium produces myo- 
blasts and myotubes (see section on Fusion) with 
an  increased PE/PC  ratio whose  magnitude  de- 
pends  on  the  ethanolamine  concentration.  As 
discussed for L6, the relative amounts of PS and/ 
or PI and Sph do not appear to change apprecia- 
bly (data not shown). Supplementing the growth 
medium with DME produces myotubes in which 
-70%  of the phospholipids are phosphatidyldi- 
methylethanolamine (PDME). 
Secondary Lipid Alterations 
We have  analyzed the cellular membranes  of 
L6 for possible secondary alterations that accom- 
pany the primary alterations of fatty acyl chains, 
polar  headgroups,  and  levels  of sterol.  An  in- 
spection of the  data presented in Tables X-XII 
reveals that many secondary changes in the lipids 
do  in fact occur;  however,  in  general, they are 
not  of a  magnitude  comparable  to  that  of the 
primary alteration. For example, the PE/PC ratio 
in Iatty acyl altered cells (Table VIII) is signifi- 
cantly lower than in control cultures, and in 25- 
OH  cholesterol-grown cells this  ratio is  signifi- 
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Fatty Acyl Alterations in the Plasma Membrane of Le Myoblasts 
Fatty acyl composition (% by weight ) 
Medium supplement  14:0  16:0  16:1  18:0 
Regular medium (4)  3.4 •  2.4  41.8 •  12.1  6.2 •  1.0  22.9 •  5.6 
LDMA +: 
Biotin (1.5 tzg/ml) (3)  4.0 -+ 0.3  33.1  •  10.5  5.7 --- 1.7  21.3  -  7.8 
Oleate (16.7/.tg/ml)  (2)  2.4 •  1.4  14.0 -  4.2  3.8 •  0.8  7.8 --- 1.8 
Elaidate (8.3 pg/ml) (2)  2.6 -  2.2  19.0 •  10.3  3.8 •  2.0  13.1  •  0.1 
Biotin  (1.5  /~g/ml)  +  5.0 •  0.8  38.2  •  3.8  1.6 •  2.3  28.1  •  5.8 
elaidate  (8.3  /xg/ml) 
(2) 
Linoleate  (8.3  /zg/ml)  4.1  •  1.1  32.1  •  2.0  5.1  •  2.3  23.7 •  5.7 
(3) 
Biotin (1.5/xg/ml) +  lin-  3.5  -  1.3  24.6 •  7.8  1.4 --- 0.4  23.3  •  10.4 
oleate (8.3/.tg/ml) (2) 
L6 cultures were  plated at a concentration of 1.8  x  10  n cells/15 ml and harvested for 
analysis on day 4. Membranes were prepared by the method of Carlsen and Till (8). 
cantly  higher.  The  relative  amounts  of  PC  and 
Sph  remain  roughly  constant,  and  hence  the 
alterations  reflect  changes  in  the  relative 
amounts  of  the  other  phospholipid  classes,  e.g. 
PS and PI. There is little, if any, difference in the 
phospholipid  composition  of  oleate-  and  elai- 
date-enriched  cultures. 
A  comparison  of the fatty acyl composition  of 
cells  possessing  altered  sterol  levels  and  PE/PC 
ratios  reveals  several  small  differences  (Table 
IX).  When the data are expressed as the fraction 
of unsaturated  fatty  acids,  there  are  only  slight 
variations.  PE-enriched  cells have a smaller frac- 
tion  of  unsaturated  fatty  acyl  positions.  This 
TABLE VI 
Sterol Alterations in Myogenic Cells 
Cholesterol (mol)/ 
Medium supplement  Free sterol  Cholesterol  Desmosterol  Sitosterol  phosl~holipid (tool) 
pg/mg protein 
Le Myoblasts 
Regular medium  23.3 -+ 1.7 (10)  23,3 -+ 1.7 (10) 
LDMB  20.8 _+ 2.3  (8)  18.6 _+ 2.5 (14) 
LDMB + 25-OH cholesterol: 
0.10~g/ml  11.6-  +  1.4  (4)  11.6-+  1.4  (4) 
0.17 p~g/ml  10.2 -+ 1.1 (12)  10.2 -+ 1.1 (12) 
0.23 p,g/ml  9.1  •  0.9  (3)  9,1  -+ 0.9  (3) 
LDMB  +  25-OH  cholesterol  (0.17  p,g/ml) 
+: 
Mevalonate (1 mg/ml)  17.5 -+ 2.0  (8)  9.8 -+ 2.5 (10) 
Cholesterol (4/.Lg/ml)  14.1 -+ 2.0  (8)  13.8 -+ 2.4  (8) 
Sitosterol(4p,  g/ml)  11.9_'1.1  (2)  10.3-+0.4  (2) 
Desmosterol (4/.~g/ml)  11.4 -+ 1.0  (2)  10.0 _* 0.7  (2) 
Primary myoblasts 
LDMB  14.9 -+ 2.3  (3)  14.3 -+  1.8  (3) 
LDMB  +  25-OH  Cholesterol  (0.63  ~g,/  11.0-+  1.1  (4)  10.4 -+  1.5  (4) 
ml) 
Primary preformed myotubes 
LDMB  35.6 -+ 3.6  (6)  31.1  -+ 4.0  (6) 
LDMB + 25-OH cholesterol  (1.2  p,g/ml)  18.8 -+ 0.5  (7)  17.4 -  0.9  (7) 
8.4 -  2.1 (t0) 
:) 
0.2 -+ 0.3  (2)  1.5 •  1.2 (2) 
1,5  -+ 0.3  (2) 
<1.0(3) 
<1.0 (4) 
4.1  -+ 1.0  (6) 
1.7 -  0.14 (7) 
0.25 _+ 0.05 (3) 
0.087 -+ 0.025 (12) 
l,s myoblasts were plated at a concentration of 0.7-1.0 x  106 cells/l 5 ml and harvested for analysis on day 3; the concentration  of biotin in the LDM was 1.5 
t~g./ml. The explanted primary cells were plated at a concentration of 8 ￿  10  ~ cells/16 ml. The myoblasts were harvested for analysis on day 3; the preformed 
myotubes were prepared by growing the explanted cells in LDMB for 3 days, at which time the 25-OH cholesterol was added; the cells were harvested for 
analysis 3 days after the addition  (day 6). 
* Variable amount of desmosterol between 4 and 30%. 
;t Variable amount of desmosterol between 0 and 16%. 
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Fatty acyl composition (% by weight) 
Un-  16c/  Double 
18:1c  18:1t  18:2  20:4  sat.  18c  bonds 
16.0 -  7.1  -  4.5  -  3.7  3.2 -  6.5  29.9  1.11  44.0 
31.5  -  3.2  -  3.6  -  0.7  -  40.8  0.69  44.4 
66.9  +- 6.2  -  2.4 -+ 3.4  2.7 -  3.8  75.8  0.23  86.3 
9.4 -+ 0.9  52.1 _+  15.5  -  -  65.3  0.31  65.3 
10.7 -+ 3.9  13.0  -+ 4.3  -  -  25.3  0.77  25.3 
19.6 -  1.2  -  14.2 -  3.0  1.1  -+ 1.9  40.0  0.65  57.5 
40.1  -  20.1  -  7.1  -  0.1  -  48.6  0.37  55.7 
decrease which arises from the low levels of 18:1 
found  in  PE-enriched cells is  one  of the  larger 
changes. When data are expressed as the ratio of 
16-carbon to 18-carbon fatty acids, the data vary 
greatly without an obvious trend. 
The sterol levels of Le possessing altered fatty 
acyl and phospholipid composition are presented 
in Table X. As with the alterations just discussed, 
the  fluctuations  are  relatively  small.  Cells  en- 
riched  in  cis-unsaturated  fatty  acids  have  the 
lowest sterol levels, whereas enrichment in etha- 
nolamine or alteration of the fatty acids produces 
the higher values. 
Fusion 
The  data  presented  in  Table  XI  and  Fig.  5 
show  the  modulations  of  myoblast  fusion  into 
multinucleate  myotubes that  accompany altered 
lipid compositions. (The myoblasts derived from 
primary  chick  explants  are  better  suited  for 
studying  fusion  than  is  L6,  which  normally  re- 
quires confluence before fusion commences. The 
fusion of primary myoblasts is largely independ- 
ent  of  cell  density;  hence  the  majority  of  our 
reported  studies  focuses  on  this  cell  type.)  A 
comparison  of the  extent of the  fusion  of myo- 
blasts  enriched in  oleate to that  of control cells 
(LDMA  and  LDMB)  or  to  those  enriched  in 
19:0  or elaidate  (18:1t)  reveals differences. The 
oleate-enriched  myoblasts  show  a  slightly  en- 
hanced  extent  of fusion  while  the  elaidate-  and 
19:0-enriched myoblasts show a marked decrease. 
A  parallel increase  in  the  fraction  of interacting 
cells, i.e., those cells that are touching one another 
but  are  neither  obviously  fused  nor  single  cells 
(see  Materials  and  Methods  and  Fig.  5)  accom- 
panies this decrease in fusion. These modulations 
of fusion are even more striking and are apparent 
at lower levels of supplementation when the myo- 
blasts are grown in a low calcium medium for 52 
h,  and  the  rate  of fusion  is  then  measured  after 
calcium  addition  (A.  Wight  and  A.  Horwitz, 
unpublished  observations).  The  inhibition  is  re- 
versible  since  the  addition  of  regular  medium 
(containing  AraC)  to  elaidate-enriched  cultures 
on day 2 enhances the extent of fusion. We have 
observed also that L 6 enriched in oleate fuses as 
does  Le  grown  for  several  passages  in  LDMA 
containing  biotin,  linoleate-biotin,  or  stearate- 
oleate.  In  addition,  the  fusion  of L6  enriched  in 
elaidate is inhibited (data not shown). 
Alterations in the extent of fusion also accom- 
pany  changes  in  the  polar  headgroup  composi- 
tion.  As the ratio of PE/PC in  primary cultures 
increases,  the  fraction  of fused  cells decreases. 
This  decrease  is accompanied by  an  increase  in 
the  fraction  of  interacting  cells;  however,  the 
magnitude  of  the  increase  does  not  appear  as 
large  as  that  observed  for  elaidate-  and  19:0- 
enriched  cells.  The  addition  of  choline  to  the 
ethanolamine-containing growth  medium at any 
time  through  day  2  reverses  the  inhibition.  In 
contrast  to  the  marked  inhibition  produced  by 
PE  enrichment,  the  inhibition  produced  by 
PDME is only slight in primary myoblasts. In L6, 
we  have  not  observed  fusion  of cells grown  in 
LDMB supplemented with either DME or etha- 
nolamine. 
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Phospholipid Alterations in Myogenic Cells 
Medium supplement  PE (mot)/PC (mol) 
L6 Myoblasts 
Regular medium  (4  /.~g/ml choline) 
(3) 
Regular medium +  choline (40  /zg/ 
ml) (2) 
Regular medium + choline (400 ~g/ 
ml (2) 
LDMB + choline (4 ~,g/ml) (14) 
LDMB (no choline) (7) 
LDMB  +  ethanolamine  (6  /~g/ml) 
(5) 
LDMB +  ethanolamine (20 ~tg/ml) 
(5) 
Primary myotubes 
LDMB + choline (4 ~tglml) (2) 
LDMB  +  ethanolamine  (3.75  /~g/ 
ml) (2) 
LDMB + ethanolamine (0.1 mg/ml) 
(2) 
0.70 -  0.05 
0.73  -  0.04 
0.68  -  0.02 
0.76 -  0.07 
1.44 -  0.20 
1.72  -+ 0.14 
2.45  _+ 0.6 
0.53  -  0.01 
1.11  _+ 0.25 
1.54  -  0.13 
L6  % PDME 
LDMB +  DME (4 p.g/ml) (2)  56.7 +_  1.8 
Primary myotubes 
LDMB +  DME (3.75 p.g/ml) (2)  71.4 +_ 1.1 
Ls myoblasts  were plated at a concentration of 5  ￿  105 
cells/15  ml  and  harvested  for  analysis  on  day  4;  the 
primary myogenic cells were plated at a concentration of 
4 ￿  10  ~ cells/16 ml and harvested on day 3. In this table, 
LDM  refers  to  lipid-depleted medium  without  exoge- 
nous choline. 
Primary myoblasts grown in LDMB containing 
25-OH cholesterol show the most dramatic inhi- 
bition  of  fusion  (Fig.  5  and  Table  XI).  This 
inhibition  is reversed by the  addition  of choles- 
terol at  any  time  through  day  2.  L8 cells,  when 
grown  under  analogous  conditions,  also  do  not 
fuse.  And  in  long-term  or  4-day  cultures  of  L~ 
grown in LDMB containing both 25-OH choles- 
terol and  mevalonate the cells do fuse,  whereas 
in those  grown in LDM containing  25-OH  cho- 
lesterol and desmosterol the cells do not fuse. In 
contrast  to  the  inhibitions  that  accompany  the 
other  lipid  alterations,  those  by  25-OH  choles- 
terol  are  not  accompanied  by  an  increase  in 
the fraction of interacting cells. 
DISCUSSION 
Regulation of the Cellular 
Lipid Composition 
The data presented show clearly that large and 
somewhat  selective  perturbations  in  the  fatty 
acyt,  phospholipid  headgroup,  and  sterol  com- 
position  can  be  produced  in  cultured  myogenic 
cells  from  a  cell line,  L6,  and  primary  explants 
from  chick  embryos.  Using  the  primaries,  we 
have  produced  alterations  in  two  cell  types, 
myoblasts  and  myotubes.  In  the  myotubes,  we 
have  produced  the  alterations  by  fusion  of  al- 
tered  myoblasts  and  by  addition  of  medium 
supplements  to  preformed  myotubes.  We chose 
to  explore  lipid  alterations  with  L6  in  greater 
detail since relatively large quantities of cells are 
more  easily  prepared.  However,  the  extent  of 
alterations  in  the  different  systems  is  compara- 
ble.  These  alterations  also  compare  favorably 
with those described for other cell types (16,  28, 
60). 
The  nature  and  extent  of the secondary  alter- 
ations  that  accompany  the  primary  alterations 
are  of some  importance  since  they  are  relevant 
to possible regulatory mechanisms that  maintain 
constant  physical  properties  of  the  membrane 
lipids.  In  general,  large  primary  alterations  of 
any  one lipid type are not  accompanied  by large 
changes  of the  other  principal  lipid  types.  Fur- 
thermore,  the  secondary  changes  do  not  ob- 
viously compensate for the primary  change.  For 
example, the enrichment  of the fatty acyl chains 
with oleate is accompanied by a  decrease  in the 
PE/PC ratio and a decrease in cellular sterol; and 
enrichment  in  PE  is accompanied  by a  decrease 
in the fraction of unsaturated  fatty acids and little 
change  in  sterol.  These  changes,  if  they  would 
have an effect, are opposite to those expected to 
preserve  physical  properties  of  the  membrane, 
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FIGURE 4 
,6-,  6-,  i  6'  ,6' 
J.l,g/mr Ethonolomine 
The effect of various concentrations of eth- 
anolamine on the growth of Lo myoblasts in choline-free 
LDM. The cells were plated at a concentration of 1.8  ￿ 
105  cells/5  ml  (indicated  by  the  arrow)  and  were 
counted on day 4. 
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Phospholipid Composition of L6 Myoblasts Possessing  Altered Levels of Sterols and Fatty Acyl Compositions 
Phospholipids 
Medium supplement  PE  PS +  PI  PC  Sph  PE/PC ratio 
Regular serum (3) 
LDMA +  biotin (1.5 /~g/ml) (3) 
LDMA +  oleate (16.7/,Lg/ml) (2) 
LDMA +  elaidate (8.3/~g/ml) (2) 
LDMA  +  biotin (1.5  /xg/ml)  +  linoleate 
(8.3/zg/ml) (2) 
LDMB  +  25-OH  cholesterol (0.17  /zg/ 
ml) (3)* 
relative % 
32.2 •  3.0  11.4 •  0.8  45.5 •  1.2  10.7 •  1.1  0.71 
29.6 -  2.2  16.5 •  2.4  44.1  •  3.1  9.8 •  1.9  0.67 
29.1  •  0.5  12.2 •  0.4  48.1  •  1.6  10.4 _+ 1.6  0.60 
28.6 -+ 1.1  16.5 -- 1.1  45.2 +_ 2.0  9.6 •  2.0  0.63 
30.2 -  0.4  11.3 -+ 2.2  46.8 •  0.8  11.6 •  1.0  0.64 
39.8 •  1.8  7.5 -  1.1  44.5 •  2.4  8.3 -+ 0.3  0.89 
The L0 cell cultures, except for those supplemented with 25-OH cholesterol, were plated at a concentration of 1.8 
x  106 cells/15 ml and harvested for analysis on day 4. 
* The cultures grown in LDMB containing 25-OH cholesterol were plated at a concentration of 7.0  ￿  106 cells/15 
ml and harvested for analysis on day 3. 
TABLE  IX 
Fatty Acyl Composition of L6 Myoblasts Possessing  Altered Levels of Cellular Sterol and Ratios of Phospholipid 
Classes 
% 
Un-  16c/  Double 
Medium supplement  14:0  16:0  16:1  18:0  18:1  18:2  20:4  sat.  18c  bonds 
LDMB  +  25-OH  choles- 
terol* 
(0.1  ~g/ml) (2)  2.4 •  1.0  24.4 •  6.6  11.8 -+  1.9  18.8 •  0.3  38.5 -~ 3.3  1.2 -+  1.7  2.9 -  0.8  54.0  0.63  64.3 
(0.2/zg/ml) (2)  2.7 •  0.8  26.6 •  0.4  15.0 -*  1.0  18.4 •  0.5  33.7 -* 0.6  -  3.6 --- 0.2  52.3  0.80  63.1 
LDMB  +  25-OH  choles- 
terol (0.2 #,g/ml)* 
+  Mevalonate  (1  mg/ml)  3.0 -  0.3  23.1  -+ 0.4  16.7 -+ 2.4  18.3 •  2.9  34.1  -+ 2.3  1.4 -+ 2.0  3.3 -  0.5  55.5  0.74  66.8 
(2) 
+  Cholesterol  (2  ~,g/ml)  2.5 -  0.8  23.8 -* 3.5  18.3 ~  2.1  16.6 -+  1.5  32.7 -+ 4.0  2.6 -+ 0.3  3.4 _+  1.1  57.0  0.81  69.8 
(2) 
LDMB  +  choline (4 ,u.g/ml)  2.1  +- 0.3  21.3 -+ 2.2  10.9 -  3.5  21.0 -* 0.8  41.4 -  0.8  2.8 -  0.8  1.1  •  1.5  56.2  0.51  62.3 
(2), 
LDMB (no choline)•  2.1  -+  1.0  22.7 +- 6.0  12.2 -+  1.0  27.3 -  1.1  29.8 -+  1.2  3.3  •  2.3  2.6 -+ 3.6  47.9  0.61  59.0 
LDMB  +  ethanolamine  (20  2.6 -  1.1  24.1  -+ 3.5  13.9 •  2.2  23.9 •  1.7  27.0 -. 0.8  6.0 -* 2.6  2.3 -+ 3.3  49.2  0.67  62.1 
tzg/ml) (2)r 
￿9 For sterol alterations, ~  myoblasts were plated at a concentration of 1.8  x  11~,  cells/15 ml in LDMB and harvested for analysis on day 4. 
For polar headgroup alterations, L~ myoblasts were plated at a concentration of 5  x  108 cells/15 ml in LDMB containing no exogenous choline and were 
harvested for analysis on day 4. 
i.e.,  bilayer order,  phase equilibria,  and self dif- 
fusion  rates  (27).  One  possible  exception  to this 
conclusion  is  the  marked  increase  in  the  PE/PC 
ratio that accompanies lowered levels of sterol. 
In  this  study,  we  have  not  explored  possible 
secondary changes in the minor lipids and mem- 
brane  protein.  Such  an  analysis  would  require 
excessive amounts of material. It seems unlikely 
that  minor  lipids  would  contribute  significantly 
to  the  bulk  bilayer  properties;  however,  they 
might be  an  important determinant of localized 
membrane properties.  On the other hand, mem- 
brane  proteins  can  contribute  substantially  to 
some  bulk  membrane  properties  such  as  acyl 
chain ordering,  and their omission poses  a  limi- 
tation on our conclusions (30, 51, 52). 
In the context of the preceding discussion, it is 
interesting that L6 cells, possessing altered lipids, 
remain  viable  and  in  many  cases  proliferate  at 
appreciable  rates  and  express  the  differentiated 
property  of  fusion.  Stearate-oleate-supple- 
mented cultures  are enriched in oleate; the bio- 
tin-supplemented cultures contain no detectable 
amounts  of  18:2  and  20:4,  two  essential  fatty 
acids; and the linoleate-biotin-supplemented cul- 
tures  are  enriched in  these  essential fatty acids. 
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Sterol Levels of L6 Myoblasts Possessing  Altered Phospholipid and Fatty Acyl Compositions 
Medium supplement  Free sterol  Desmosterol  Cholesterol 
LDMA + biotin (1.5/~g/ml)* 
LDMA + oleate (16.7 ~g/ml)* 
LDMA + elaidate (8.3/.~g/ml)* 
LDMA +  linoleate (8.3/zg/ml)* 
LDMA  +  linoleate (8.3  ~g/ml)  +  biotin  (1.5  p.g/ 
ml)* 
LDMB (no choline):~ 
LDMB (no choline) +  ethanolamine (10/xg/ml):~ 
LDMB (no choline) +  ethanolamine (20 p.g/ml)~t 
~g/mg protein 
20.4 +_ 1.44 (5)  4.2 _+ 2.6 (5)  16.1  •  2.1  (5) 
19.1  -+ 3.1  (4)  4.2 -+ 1.4 (4)  15.0 •  2.6 (4) 
24.3 -+ 1.8 (3)  3.9 _+ 3.6 (3)  20.4 •  4.7 (3) 
17.5  -- 0.5 (4)  1.5  •  0.7 (4)  16.0 •  2.7 (4) 
18.7  -4- 3.7 (4)  6.3 _+  1.5 (4)  12.4  •  3.0 (4) 
22.4 ___ 1.9 (4)  1.7 +_ 0.4 (4)  20.3 -+ 2.0 (4) 
23.1  -+ 2.9 (4)  1.7  -+ 0.5 (4)  21.4 •  2.7 (4) 
27.2 -- 1.5 (3)  5.9 •  3.9 (3)  21.3 -+ 5.4 (3) 
* I-.6 myoblasts grown in LDMA containing fatty acids or biotin were plated at a concentration of 1.8  ￿  10  ~ cells/15 
ml and harvested for analysis on days 3-4. 
:~ For  headgroup  alterations,  1..6 myoblasts  were plated  at  a  concentration  of 5.0  ￿  1@  cells/15  ml in  LDMB 
containing no exogenous choline and were harvested for analysis on day 4. 
These  cells  proliferate  through  several  popula- 
tion  doublings,  if  not  indefinitely,  and  fuse  to 
form  myotubes.  Similarly,  mevalonate-  or  des- 
mosterol-reversed  25-OH  cholesterol-supple- 
mented  cultures  have  lowered  levels of choles- 
terol and also proliferate at least through several 
population  doublings,  and  the  mevalonate-re- 
versed cells fuse to form myotubes.S 
Although L6 appears to tolerate some variabil- 
ity,  there  appear  to  be  limits.  The  cells in  des- 
mosterol-reversed  25-OH  cholesterol-supple- 
mented  cultures,  which  possess  lowered  sterol 
levels and proliferate through several population 
doublings,  do  not  fuse.  Furthermore,  the  maxi- 
mum decrease in sterol using the 25-OH choles- 
terol  procedure  is  two-  to  threefold.  The  de- 
crease is accompanied by a  cessation of prolifer- 
ation and an inhibition of fusion. This magnitude 
of decrease  is seen  in  both  proliferating  L6  and 
resting (myotube) cells and is comparable to that 
produced  by another  method  (53).  Attempts  to 
further  decrease  the sterol level by using higher 
levels  of  inhibitors  or  lower  densities  of  cells 
result  in  decreased  viability.  It  is  difficult  to 
ascertain  whether  these  apparent  limits  arise 
5 In L8 cultures supplemented with mevalonate and 25- 
OH  cholesterol,  the  cholesterol  levels  can  become 
equal to or lower than those of the inhibited (25-OH 
cholesterol supplemented) cultures. However, the total 
steroi  content  (cholesterol  and  desmosterol)  is  well 
above that of the inhibited cells. The implication is that 
desmosterol, like cholesterol, can function as a structural 
component of the membrane. 
from altered critical physical membrane  proper- 
ties since the amount of cholesterol varies among 
the  subcellular  membrane  fractions  and  may be 
disposed  asymmetrically  in  the  membrane  (7, 
46).  However, our estimates of the plasma mem- 
brane  cholesterol content  (based  on the data  of 
Kent  et  al.  (33)  in  the  altered  cells is  close  to 
20%, a  value at which the physical properties of 
the  bilayer  may well change  (J.  Sturtevant,  un- 
published communication). 
It  is  difficult  to  ascertain  whether  an  upper 
bound  also  exists  on  the  sterol  level, since  the 
uptake  of microcrystalline cholesterol cannot  be 
easily excluded. Others, however, have reported 
that  the levels of cholesteryl ester increase as the 
cholesterol  concentration  in  the  medium  in- 
creases. This conversion may be a  mechanism to 
buffer the cholesterol level analogous  to that  of 
triglyceride  formation  for  fatty  acids  (44,  45). 
Van  der  Bosch  et  al.  (58)  have  reported  that 
myoblast  fusion is inhibited when  myoblasts  are 
grown under  conditions thought  to increase cel- 
lular  sterol  levels.  It  is  also  possible  that  this 
apparent  upper limit arises from altered, critical, 
physical properties of the membrane. 
It  is  interesting  that  cells  grown  in  DMEM 
containing either regular or lipid-depleted serum 
have comparable cholesterol levels. In one case, 
the  sterol  is  derived  exogenously  from  a  large 
extracellular pool,  and  in the  other via endoge- 
nous  pathways.  This  not  only  reflects  an  upper 
limit or optimal amount of cholesterol in the cell, 
but it also suggests that  without  perturbation  the 
cholesterol levels are regulated. 
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sition  also  appears  limited  and  regulated. 
Whereas  PDME  can  partially replace  PC  and 
support  proliferation  and  myoblast  fusion,  L6 
grown  on  DME  does not survive repeated sub- 
culturing and PDME does not totally replace PC 
(or PE). Furthermore, increasing the amount of 
ethanolamine  produces  increasing  amounts  of 
PE; however, increments of PE exceeding -2 x 
that of the control are accompanied by decreased 
fusion  and  viability and/or  attachment  to  the 
substratum. In contrast, the ratio of PE/PC,  the 
two major phospholipid classes, is changed little, 
if  any,  by  growing  L6  or  primaries  in  media 
containing regular serum, regular serum contain- 
ing  100x  the  normal  amount  of  choline,  or 
LDM.  In the first two, choline is available both 
in the free form and as lecithin while in the latter 
only as free choline. 
The  fatty acyl composition appears more tol- 
erant  of variation  and  less  precisely regulated; 
however, we have not yet achieved total replace- 
ment by a single fatty acid. The limit for oleate 
enrichment appears to be ~65-70%  of the fatty 
acyl chains, and that for elaidate slightly higher. 
Our  attempts  to  enrich  further  in  oleate  or 
septadecanoate by subculturing were not success- 
ful.  6 Whether these apparent limits arise biosyn- 
thetically or metabolically or from altered physi- 
cal  properties of the  membrane  remains  to  be 
determined.  In elaidate-enriched cells, we have 
presented  correlative  evidence  consistent  with 
the latter explanation (23, 24). Since the fraction 
of unsaturated fatty acid in control and saturated 
fatty  acid-supplemented cells is  somewhat  con- 
stant, this parameter appears regulated. 
The  data on  fatty acyl alterations show  clear 
evidence for metabolism of the fatty acid supple- 
ments.  In  nonadecanoate-supplemented  cells, 
appreciable amounts of 19:0,  19:1, and traces of 
17:0  and  17:1  are  present,  providing evidence 
for elongation and desaturation. In addition, L6 
also elongates 18:2 to form 20:4 since a dramatic 
increase  in  20:4  accompanies  enrichment  in 
18:2.  These  results  contrast  with  those  with  L 
cells which neither desaturate 19:0 nor elongate 
18:2 (14, 60). 
Since detailed compositional studies on subcel- 
lular membrane fractions are not reported here, 
we consider our discussion only suggestive. With 
one  exception,  the  analyses  presented  are  an 
average  from  all  cellular membranes  and  may 
not accurately reflect the composition of any par- 
ticular membrane fraction. A  detailed analysis of 
membrane  fractions  is  more  appropriately pur- 
sued using a cell type from which a large number 
of cells are  readily propagated and  pure  mem- 
branes prepared (49). This latter requirement is 
complicated by the difficulties in preparing pure 
and  intact  membranes  from  cultured  cells (13, 
48). Studies of analogous modifications in L cells 
show enrichments in the plasma membrane that 
parallel those detected in the whole cell analyses, 
and  it  seems  reasonable  to  expect  a  similar 
parallel in these myogenic cells as well (15,  32, 
49). 
This expectation is supported by our observa- 
tions  of modulations  in  fusion  that  accompany 
the lipid alterations and by our limited analyses 
of plasma  membrane  fractions  from  fatty  acyl 
altered cells. With respect to the latter, the high 
level of 16:0 and fraction saturated fatty acid in 
the control cultures and the relatively low enrich- 
ment in the linoleate and especially in the lino- 
leate-biotin and elaidate-biotin supplemented cul- 
tures is unexpected. It remains to be established 
whether  these  surprising observations are  some- 
how artifactual, by using other membrane prepa- 
rations, cell types, growth conditions, and analyti- 
cal  procedures.  If  not,  they  provide  a  possible 
explanation for the effect of biotin in  promoting 
the proliferation of elaidate- and linoleate-supple- 
mented  cells.  In  addition,  since  the  fatty  acyl 
replacement is more complete in whole cell lipids 
than  plasma membrane  lipids when  cultures are 
supplemented  with  both  fatty  acids  and  biotin, 
they also imply that the assembly route for lipids 
of one  plasma membrane  may  rely  on  de novo 
synthesis to a greater extent than internal cellular 
membranes. 
6 Our observation that oleate- and septadecanoate-sup- 
plemented cultures exhibit some continued prolifera- 
tion without a parallel increase in the extent of supple- 
mentation can be explained by the utilization of the 
residual  lipid  present  in  the  extracted  serum  (see 
Materials and Methods). 
Modulations of Fusion by Altered 
Lipid Compositions 
The  marked  modulations  of  myoblast fusion 
that  accompany  the  lipid  alterations  not  only 
suggest  that  the  plasma  membrane  lipids  are 
Hoswrrz  ET  AL.  Membrane  Lipids and Myoblast Fusion  351 FIGURE  5  The fusion and morphology of primary cultures possessing altered lipid compositions. The 
cultures were plated at 0.25  ￿  106 cells/ml (a, c, and d) or 0.5  ￿  106 cells/ml (b) and were cultured in 
the indicated medium. The phase-contrast pictures were taken of living cultures on day 3.  (a) LDMA 
containing biotin (1.25  /zg/ml). AraC was added on day 2. (b) LDMB containing 25-OH cholesterol 
(0.63/.Lg/ml).  AraC was added on day 1. (c) LDMA containing oleate (21  /~g/ml). AraC was added on 
day 2. (d) LDMA containing elaidate (21  ~g/ml). AraC was added on day 2. Bar, 100/~m. 
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into  the  mechanism  of  myoblast  fusion.  The 
nature of the influence of the lipid alterations on 
fusion  is  likely complex.  We  consider  possible 
toxic effects of the lipid alterations or the lipid- 
altering  procedures  an  unlikely mechanism  for 
several reasons:  (a)  The  different  lipid  altera- 
tions influence  fusion  differently. For example, 
myoblast fusion  is  enhanced  in  oleate-enriched 
cells and inhibited in cells enriched in elaidate or 
grown in LDM containing 25-OH cholesterol. In 
the elaidate-enriched cells, an  increase in inter- 
Hogwrrz  E'r AL.  Membrane Lipids and Myoblast Fusion  353 TABLE XI 
Fusion of Primary Chick Myoblasts 
Medium supplement  Fusion  Interacting  cells  No. nuclei/tube  No. nuclei/field 
%  % 
LDMA +  biotin* 
(1.25 p,g/ml) (2)  65 -+ 7  2.2 4- 0.4  12 _+ 4  67 _+ 2 
LDMA +  oleate* 
(10.4 p,g/ml) (2)  80 +  2  1.9 _+  1.2  18.6  +  0.6  83 -+  18 
(20.8/,g/ml) (2)  75  4- 5  1.1  -+  1.6  18.8  _+ 3.0  71  +  22 
LDMA +  elaidate* 
(10.4 p,g/ml) (2)  64 _  8  11  -+  1  9.2 _+ 2.1  76 _+  6 
(20.8 p,g/ml) (2)  46 -+  12  19 --+ 5  5.9 -  2.2  63 -+  i0 
(31.3/zg/ml) (2)  23  _+ 2  28 -+ 6  3.5 -  0.1  51  -+ 7 
LDMA +  nonadecanoate* 
(2.6/,g/ml) (3)  42 _  15  32 +  9  5.1  -+ 1.2  61  -+ 7 
(5.2 p,g/ml) (3)  30 +  5  37 +  4  4.2 _+ 0.7  11  -+  10 
LDMB  +  25-OH  cholesterol (0.63  /,g/ml)  17 -+ 9  2.0 -+ 1.4  4.9 _  1.4  64 --+ 24 
(2):~ 
+  Cholesterol (5 ~g/ml) (day O) (3)  62  +  11  9.0 +  8.5  13 -+ 6  108 +  38 
+  Cholesterol (5/,g/ml) (day 2) (2)  43  +  3  9.5  -+ 8  7.9 +  2.2  55 +  31 
+  Regular medium (day 2) (2)  51  m 5  6.3 -+ 2.5  9.2 -+ 0.7  73 +  23 
LDMB +  ethanolamine (0.1  mg/ml) (2)~  18 _  8  14 -+  13  4.9 -+ 2.4  37  -+ 6 
+  Choline (4/,g/ml) (day 0) (2)  75 -+ 6  1.5 -+ 0.7  13 -+ 7  78 -+ 32 
+  Choline (4 p.g/ml) (day 2) (2)  57 _+ 4  7 -+  1  9.5 -+ 0.2  41  _+ 8 
+  Regular medium (day 2) (2)  65 -  5  7 -  7  11  -  3  57 -_+ 3 
LDMB +  DME~: 
(3.75  p.g/ml) (2)  58 -+ 4  6 -  3  9.4 -  1.3  65  -+ 8 
For studies involving fatty awl and polar headgroup alterations, the cells were plated at a concentration of 5  ￿  105 
cells/2 ml and for sterol alterations at a concentration of i  ￿  10  ~ cells/2 ml. In some experiments, a further addition 
was made on either day 0 or day 2; this was done by simply adding the agent to the medium in the culture plate, 
except when regular medium was added, in which case the old medium was first removed. 
* LDMA contained 2 p,g/ml avidin. 
:~ LDMA contained 1.25/zg/ml avidin. 
acting cells accompanies the inhibition of fusion; 
this does not occur in cells with lowered levels of 
sterol.  The  presence  of  interacting  cells  in  the 
elaidate- (and possibly in  the PE-) enriched cells 
indicates that  migratory  and  adhesive phenom- 
ena  have  occurred,  r  (b)  Although  decreases in 
viability  accompany some of the  alterations, in 
general, the extent of fusion  does not correlate 
directly with the remaining number of cells. (c) 
7 The  morphologies seen in  Fig.  5  show clear differ- 
ences between oleate- and elaidate-enriched and control 
cultures.  The  myotubes that form in  oleate-enriched 
cultures have a saclike morphology very similar to that 
of the myosacs formed by colecmid treatment of my- 
otubes (3).  Elaidate  enrichment, on  the other hand, 
results in relatively thin myotubes. This effect could be 
direct via a  coupling between the lipids and the cyto- 
skeleton and/or a  differential adhesion to the substra- 
tum,  or  it  could  be  indirect  through  any  one  of  a 
number of mechanisms. 
The  reversibility of the  inhibitions even  in  the 
absence  of  cell  division  shows  that  the  cells 
remain viable. The addition of choline or choles- 
terol to  PE-enriched ceils or to  those with low- 
ered sterol levels, respectively, reverses the inhi- 
bition. In sum, a  more likely explanation for the 
influence of the lipid alterations is via changes in 
the  membrane lipids directly influencing the fu- 
sion process per se. 
As discussed above, the fatty acyl enrichments 
appear to influence fusion differently than does 
the lowering of sterol levels by  inhibiting sterol 
synthesis. This implies different mechanisms of 
inhibition. We  have recently provided evidence 
supporting a  model in which fusion proceeds via 
a  sequence of events (35,  36). In the context of 
this model, the differential influence of the lipid 
alterations  on  fusion  would  arise  by  inhibiting 
different stages of the  process. Thus,  the  fatty 
acyl  and  PE  enrichments  would  inhibit  after 
354  THE  JOURNAL OF  CELL BIOLOGY " VOLUME 77, 1978 myoblast  recognition  but  before  membrane  un- 
ion. The  lowered  sterol levels would  inhibit the 
recognition process or some event before it; the 
PE enrichments may have a  secondary influence 
at  this stage  as well.  This  interpretation  is sup- 
ported by our recent studies of fusion in suspen- 
sion. These  studies  as well  as  a  more  complete 
discussion  and  presentation  of  data  concerning 
the  role  of  lipids  in  fusion  will  be  presented 
elsewhere. 
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